124 related articles for article (PubMed ID: 14637261)
1. Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome.
Xu ZM; Zhao SP; Li QZ; Nie S; Zhou HN
Clin Chim Acta; 2003 Dec; 338(1-2):17-24. PubMed ID: 14637261
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.
Kowalski J; Okopień B; Madej A; Zieliński M; Belowski D; Kalina Z; Herman ZS
Eur J Clin Pharmacol; 2003 Jul; 59(3):189-93. PubMed ID: 12756509
[TBL] [Abstract][Full Text] [Related]
3. [Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes in patients with acute myocardial infarction and modulates the early inflammatory response].
Deng P; Zhao SP; Wu J; Hong SC; Wu ZH; Zhou HN; Nie S
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Nov; 33(11):1018-22. PubMed ID: 16563251
[TBL] [Abstract][Full Text] [Related]
4. Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.
Grip O; Janciauskiene S; Lindgren S
Inflamm Bowel Dis; 2004 May; 10(3):193-200. PubMed ID: 15290911
[TBL] [Abstract][Full Text] [Related]
5. The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.
Zhou T; Zhou SH; Qi SS; Shen XQ; Zeng GF; Zhou HN
Clin Chim Acta; 2006 Jun; 368(1-2):168-72. PubMed ID: 16480969
[TBL] [Abstract][Full Text] [Related]
6. [Effect of atorvastatin on advanced glycation end products induced monocyte chemoattractant protein-1 expression in cultured human endothelial cells].
Xu SH; Wang KF; Xu CS; Xie LD
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):512-7. PubMed ID: 21924076
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses.
Mirjanic-Azaric B; Rizzo M; Sormaz L; Stojanovic D; Uletilovic S; Sodin-Semrl S; Lakota K; Artenjak A; Marc J; Cerne D
Clin Biochem; 2013 Oct; 46(15):1526-31. PubMed ID: 23792106
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
9. [Atorvastatin inhibits scavenger receptor A and monocyte chemoattractant protein-1 expressions in foam cell].
Zhu GY; Zhu XL; Li RT; Liu TB; Shang DY; Zhang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):666-9. PubMed ID: 17961438
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response.
Deng P; Zhao SP; Dai HY; Guan XS; Huang HG
Clin Chem; 2006 Feb; 52(2):300-3. PubMed ID: 16449211
[TBL] [Abstract][Full Text] [Related]
11. [The effects of atorvastatin on C-reactive protein induced Toll-like receptor 4 expression on CD14+ monocyte].
Peng L; Luo YT; Liu JL
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jul; 39(7):664-9. PubMed ID: 22088250
[TBL] [Abstract][Full Text] [Related]
12. [Influence of atorvastatin on the expression of monocyte chemoattractant protein-1 in peritoneal mesothelial cells by high glucose].
Li ZM; Ma JF; Wang LN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2677-80. PubMed ID: 18167242
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes.
Grip O; Janciauskiene S; Lindgren S
Inflamm Res; 2002 Feb; 51(2):58-62. PubMed ID: 11926313
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.
Nie P; Li D; Hu L; Jin S; Yu Y; Cai Z; Shao Q; Shen J; Yi J; Xiao H; Shen L; He B
PLoS One; 2014; 9(5):e97009. PubMed ID: 24816562
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells.
Tanimoto A; Murata Y; Wang KY; Tsutsui M; Kohno K; Sasaguri Y
J Biol Chem; 2008 Feb; 283(8):4643-51. PubMed ID: 18089573
[TBL] [Abstract][Full Text] [Related]
16. Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis.
Martín-Ventura JL; Muñoz-Garcia B; Blanco-Colio LM; Martín-Conejero A; Madrigal-Matute J; Vega M; Ortega L; Serrano J; Egido J
Kidney Int Suppl; 2008 Dec; (111):S71-4. PubMed ID: 19034332
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
Bustos C; Hernández-Presa MA; Ortego M; Tuñón J; Ortega L; Pérez F; Díaz C; Hernández G; Egido J
J Am Coll Cardiol; 1998 Dec; 32(7):2057-64. PubMed ID: 9857893
[TBL] [Abstract][Full Text] [Related]
18. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month.
Martín-Ventura JL; Blanco-Colio LM; Gómez-Hernández A; Muñoz-García B; Vega M; Serrano J; Ortega L; Hernández G; Tuñón J; Egido J
Stroke; 2005 Aug; 36(8):1796-800. PubMed ID: 16020773
[TBL] [Abstract][Full Text] [Related]
19. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
Am Heart J; 2007 May; 153(5):881-8. PubMed ID: 17452168
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial.
Loughrey BV; McGinty A; Young IS; McCance DR; Powell LA
Clin Endocrinol (Oxf); 2013 Dec; 79(6):800-6. PubMed ID: 23170936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
